S. W. Lawrence, MD·Sep 23, 2024HIV Prophylaxis in At-risk MenAAAS: “Shots prevent HIV in at-risk men.” A new milestone in public health: “A drug injected just twice a year has demonstrated a…
Michael Saei·Sep 10, 2020Gilead Sciences Renews Support of PARS Equality CenterMichael Saei, president of First Financial Capital in Los Angeles, is a supporter of the PARS Equality Center. In 2019, Michael Saei…
Sherry AN·Aug 27, 2020Is Gilead ($GILD) Stock a buy at $65?Recently Gilead Science has been in hot discussion, due to it’s medicine Remdesivir helped Covid-19 patients from recovering. But recently…
Divya Guha·Jul 4, 2020Indian media’s hustle for Big Pharma bares conflicts of interestSome media outlets sold propaganda for remdesivir. Hindustan Times peddled a drug its owners have a commercial interest in.
Rashmee Roshan Lall·Jul 3, 2020The moral case for the world to have access to covid-19 drugAs someone with a vested interest in Gilead Sciences, the company that makes the covid-19 drug remdesivir, I’m looking for a return on…
Lifestyle Uganda·May 1, 2020Gilead Sciences COVID-19 Drug Is A Hope In Pandemic Fight — Lifestyle UGOn Wednesday, Gilead Sciences Inc. announced it had concluded its clinical trial of a COVID-19 treatment -with astonishing results.
Bare Sky Marketing — Healthcare Content Writing·Mar 22, 2020Gilead Sciences’ Epclusa Scores Pediatric Hep C WinSupplemental application to treat hepatitis C approved by FDA
Elliott Wave Forecast·Mar 9, 2020Elliott Wave View: Gilead Sciences ($GILD) Bullish Cycle Heating UpGilead Sciences ($GILD) showing signs that it may be in the beginning stages of new bullish cycle. The Long term chart shows a completed…
InKin + CartabyDr Pamela Walker·Nov 11, 2019Gilead’s Lucy Heapy: Digital Transformation is Simply ‘Strategy’ in a Digital WorldLucy Heapy emphasizes the importance of leadership driving digital transformation to push the boundaries of possibility in pharma.
TKO Society Editors·Nov 30, 2018Gilead COMPASS Funds 29 Southern Organizations Through 2021 Transformative Grants!Read Full Press Release
